Press releases

ANNUAL RESULTS – 2017

April 3rd 2018

VALBIOTIS announces its consolidated results for 2017 and presents a progress report on its development program.

Read more

Dr. Christine Roy-Duval appointed as Director of Development and Medical Affairs

March 21st 2018

VALBIOTIS appoints Dr. Christine Roy-Duval as Director of Development and Medical Affairs.

Read more

VALBIOTIS obtains strategic patent for VALEDIA® in the United States

March 15th 2018

VALBIOTIS obtains strategic patent for VALEDIA® in the United States, with the highest degree of protection.

Read more

LpD64 acts on alterations of the microbiota involved in the development of obesity

March 6th 2018

VALBIOTIS announces results showing that LpD64 acts on alterations of the microbiota involved in the development of obesity

Read more